Biocartis Group NV (BIOGF)
USD 0.66
(-85.33%)
USD 0.66
(-85.33%)
| Breakdown | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|
| Revenue | 57.48 Million | 48.26 Million | 43.12 Million | 37.44 Million |
| Cost of Revenue | 29.79 Million | 33.92 Million | 26.28 Million | 21.32 Million |
| Gross Profit | 27.68 Million | 14.34 Million | 16.84 Million | 16.11 Million |
| Operating Expenses | 74.43 Million | 76.64 Million | 63.22 Million | 71.46 Million |
| Selling, General and Administrative Expenses | 8.57 Million | 6.4 Million | 6.54 Million | 9.81 Million |
| Research and Development Expenses | 38.39 Million | 48.05 Million | 40.92 Million | 39.84 Million |
| Other Expenses | 27.46 Million | - | - | - |
| Cost and Expenses | 104.23 Million | 110.56 Million | 89.51 Million | 92.78 Million |
| Operating Income | -47.04 Million | -62.64 Million | -46.86 Million | -55.6 Million |
| Interest Expense | 11.18 Million | 9.32 Million | 10.18 Million | 7.09 Million |
| Income Tax Expense | -240 Thousand | -243 Thousand | -228 Thousand | -99 Thousand |
| Earnings before Tax | -65.62 Million | -71.71 Million | -63.16 Million | -64.16 Million |
| Net Income | -65.38 Million | -71.47 Million | -62.93 Million | -64.06 Million |
| Earnings Per Share Basic | -1.08 | -1.24 | -1.11 | -1.14 |
| Earnings Per Share Diluted | -1.08 | -1.24 | -1.11 | -1.14 |
| Weighted Average Shares Outstanding | 60.54 Million | 57.54 Million | 56.61 Million | 56.07 Million |
| Weighted Average Shares Outstanding (Diluted) | 60.54 Million | 57.54 Million | 56.61 Million | 56.07 Million |
| Gross Margin | 0.48 | 0.30 | 0.39 | 0.43 |
| EBIT Margin | -0.76 | -1.08 | -0.99 | -1.26 |
| Profit Margin | -1.14 | -1.48 | -1.46 | -1.71 |
| EBITDA | -43.95 Million | -52.55 Million | -43.23 Million | -47.34 Million |
| Earnings Before Tax Margin | -0.82 | -1.30 | -1.09 | -1.48 |
| Breakdown | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 FY | 2022 Q3 | 2021 FY |
|---|---|---|---|---|---|---|
| Revenue | 14.8 Thousand | 14.8 Thousand | 15.6 Thousand | 57.48 Million | 15.6 Thousand | 48.26 Million |
| Cost of Revenue | 15.73 Thousand | 15.73 Thousand | 17.02 Thousand | 29.79 Million | 17.02 Thousand | 33.92 Million |
| Gross Profit | -926.00 | -926.00 | -1419.00 | 27.68 Million | -1419.00 | 14.34 Million |
| Operating Expenses | 9455.00 | 9894.65 | 13.73 Thousand | 74.43 Million | 13.73 Thousand | 76.64 Million |
| Selling, General and Administrative Expenses | 9455.00 | 9455.00 | 9202.50 | - | 9202.50 | - |
| Research and Development Expenses | 9045.50 | 9045.50 | 9571.00 | - | 9571.00 | - |
| Other Expenses | -9045.50 | - | - | - | - | - |
| Cost and Expenses | 25.18 Thousand | 25.62 Thousand | 30.75 Thousand | 104.23 Million | 30.75 Thousand | 110.56 Million |
| Operating Income | -10.38 Thousand | -10.38 Thousand | -10.62 Thousand | -47.04 Million | -10.62 Thousand | -62.64 Million |
| Interest Expense | - | - | - | 11.18 Million | - | 9.32 Million |
| Income Tax Expense | 11.50 | 11.50 | 72.00 | -240 Thousand | 72.00 | -243 Thousand |
| Earnings before Tax | -15.63 Thousand | -15.63 Thousand | -18.37 Thousand | -65.62 Million | -18.37 Thousand | -71.71 Million |
| Net Income | -15.62 Thousand | -15.62 Thousand | -18.3 Thousand | -65.38 Million | -18.3 Thousand | -71.47 Million |
| Earnings Per Share Basic | -0.17 | -0.17 | -0.29 | - | -0.29 | - |
| Earnings Per Share Diluted | -0.17 | -0.17 | -0.29 | - | -0.29 | - |
| Weighted Average Shares Outstanding | 93.23 Thousand | 93.23 Thousand | 63.54 Thousand | 60.54 Million | 63.54 Thousand | 57.54 Million |
| Weighted Average Shares Outstanding (Diluted) | 93.23 Thousand | 93.23 Thousand | 63.54 Thousand | 60.54 Million | 63.54 Thousand | 57.54 Million |
| Gross Margin | -0.06 | -0.06 | -0.09 | 0.48 | -0.09 | 0.30 |
| EBIT Margin | -0.53 | -0.53 | -0.51 | - | -0.51 | - |
| Profit Margin | -1.06 | -1.06 | -1.17 | -1.14 | -1.17 | -1.48 |
| EBITDA | -7786.00 | -7786.00 | -8025.00 | - | -8025.00 | - |
| Earnings Before Tax Margin | -0.70 | -0.70 | -0.68 | -0.82 | -0.68 | -1.30 |
1023
RGXTF
CTS
000158
CCHBF
SO